SavedAdd your journal

Journals / Türk Oftalmoloji Dergisi / 2016 / Cilt: 46 - Sayı: 1

Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis

İnterferon Tedavisi Alan Multipl Sklerozlu Bir Olguda Gelişen Periferik Vaskülit ve İntermediyer Üveit

Haluk ESGİN
Şeref KİNYAS
Pages
41–43
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we share the findings and the management of intermediate uveitis and retinal periphlebitis in an MS case being treated with interferon beta-1a for 7 years

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
📊
Key Findings & Data:A 40-year-old female patient with a 12-year history of MS was admitted to our clinic with blurred vision and floaters in her right eye for about 1 month.
💡
Conclusion & Impact:Here, we share the findings and the management of intermediate uveitis and retinal periphlebitis in an MS case being treated with interferon beta-1a for 7 years
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. A 40-year-old female patient with a 12-year history of MS was admitted to our clinic with blurred vision and floaters in her right eye for about 1 month. Here, we share the findings and the management of intermediate uveitis and retinal periphlebitis in an MS case being treated with interferon beta-1a for 7 years

Özet

Multipl skleroz (MS), santral sinir sisteminin kronik enflamatuvar demiyelinizan bir hastalığıdır. On iki yıldır MS tanısı olan 40 yaşındaki kadın hasta, sağ gözde yaklaşık 1 aydır bulanık görme ve uçuşan cisimcikler şikayetleri ile kliniğimize başvurdu. Yedi yıldır interferon ?-1a tedavisiyle takip edilmekte olan olgudaki intermedier üveit ve retinal periflebit tablosunun seyri paylaşılmıştır

🔖

Cite This Article

ESGİN, H., KİNYAS, Ş. (2022). Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis. Türk Oftalmoloji Dergisi, Cilt: 46 - Sayı: 1, 41–43. https://ajindex.com/articles/637916

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Soylu M. Multiple skleroz. Ret-Vit. 2012;20:Özel Sayı:136-139. Rucker CW. Sheathing of the retinal veins in multiple sclerosis. Mayo Clin Proc. 1944;19:176-178.
  2. Mehta LR, Goodman AD. Disease-Modifying Therapies. Continuum: Lifelong Learning in Neurology. 2007;13:144-180.
  3. Graves J, Balcer LJ. Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol. 2010;4:1409-1422.
  4. Yılmaz T, Yıldırım S, Aydemir O, Çelebi S, Kükner AŞ. Multiple sklerozisli bir olguda retina periflebiti ve üveit. Ret-Vit. 2003;11:41-45.
  5. Okada AA, Keino H, Fukai T, Sakai J, Usui M, Mizuguchi J. Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm. 1998;6:215-226.
  6. Becker MD, Heiligenhaus A, Hudde T, Storch-Hagenlocher B, Wildemann B, Barisani-Asenbauer T, Thimm C, Stübiger N, Trieschmann M, Fiehn C. Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophtalmol. 2005;89:1254-1257.
  7. Gungor SR, Akova YA, Akar E. Multipl Skleroz ile İlişkili Üveitler. Turk J Ophthalmol. 2012;42:462-465.
  8. Wakefield D, Jennings A, McCluskey PJ. Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis. Clin Experiment Ophthalmol. 2000;28:103-106. Friedman SM. Retinal vasculitis as the initial presentation of multiple sclerosis. Retina. 2005;25:218-219.